Cargando…
Patient Specification Quality Assurance for Glioblastoma Multiforme Brain Tumors Treated with Intensity Modulated Radiation Therapy
The aim of this study was to evaluate the significance of performing patient specification quality assurance for patients diagnosed with glioblastoma multiforme treated with intensity modulated radiation therapy. The study evaluated ten intensity modulated radiation therapy treatment plans using 10...
Autor principal: | Al-Mohammed, H. I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156993/ https://www.ncbi.nlm.nih.gov/pubmed/21850196 |
Ejemplares similares
-
Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme
por: Fuller, Clifton D, et al.
Publicado: (2007) -
Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme
por: Aherne, Noel J., et al.
Publicado: (2014) -
A management method for the statistical results of patient-specific quality assurance for intensity-modulated radiation therapy
por: Nakamura, Satoshi, et al.
Publicado: (2017) -
Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
por: Jastaniyah, Noha, et al.
Publicado: (2013) -
A study to establish reasonable action limits for patient‐specific quality assurance in intensity‐modulated radiation therapy
por: Both, Stefan, et al.
Publicado: (2007)